Norway vs Sub-Saharan Africa (IDA & IBRD countries): Immunization, HepB3
Norway
96.0%
in 2024
Sub-Saharan Africa (IDA & IBRD countries)
74.0%
in 2024
Norway rank
42nd
Sub-Saharan Africa (IDA & IBRD countries) rank
41st
Immunization, HepB3 over time
- Norway
- Sub-Saharan Africa (IDA & IBRD countries)
How they compare
Norway currently reports 96.0% against 74.0% in Sub-Saharan Africa (IDA & IBRD countries), a difference of 22.0%.
That makes Norway's figure about 1.3 times Sub-Saharan Africa (IDA & IBRD countries)'s.
Across all 6 years both countries report, Norway has been ahead every year.
Norway ranks 42nd and Sub-Saharan Africa (IDA & IBRD countries) ranks 41st of 188 countries.
Norway has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Norway | Sub-Saharan Africa (IDA & IBRD countries) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 96.0% | 76.3% | 19.7% | Norway |
| 2020s | 96.2% | 73.4% | 22.8% | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, Norway or Sub-Saharan Africa (IDA & IBRD countries)?
- Norway, at 96.0% against 74.0% in Sub-Saharan Africa (IDA & IBRD countries) as of 2024.
- What is the difference in immunization, hepb3 between Norway and Sub-Saharan Africa (IDA & IBRD countries)?
- 22.0%, with Norway ahead.
- How many years of comparable data are there for Norway and Sub-Saharan Africa (IDA & IBRD countries)?
- 6 years are reported by both, from 2019 to 2024.
- How do Norway and Sub-Saharan Africa (IDA & IBRD countries) rank globally for immunization, hepb3?
- Norway ranks 42nd and Sub-Saharan Africa (IDA & IBRD countries) ranks 41st of 188 countries.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.